G1 Therapeutics (GTHX) Competitor Comparison
We are evaluating the key criteria listed to compare G1 Therapeutics (GTHX) against its competitors in the Biotechnology industry.
Market Capitalization
252 / 368Gross Profits
65 / 278Total Revenue
101 / 300EBITDA
150 / 337Free Cashflow
162 / 352Quick Ratio
258 / 357Earnings per Share
113 / 359Dividend yield
0 / 6Total Cash
219 / 358Performance 3 years
165 / 368Performance 5 years
237 / 368Performance 10 years
156 / 368Linearity 3 years
144 / 368Linearity 5 years
234 / 368Linearity 10 years
55 / 368Total Rank
133 / 368Dividend Rank
137 / 368Valuation Rank
157 / 368Piotroski Rank
345 / 368Muliplier Rank
87 / 368Earnings per Share - GTHX ranking 113 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.